Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Dr. Falk Pharma UK Ltd
Bourne End Business Park, Cores End Road, Bourne End, Buckinghamshire, SL8 5AS
Telephone: +44 (0)1628 536 600
Fax: +44 (0)1628 536 601
Medical Information Direct Line: +44 (0)1628 536 616
Customer Care direct line: +44 (0)1628 536 600
Medical Information Fax: +44 (0)1628 536 601
Out of Hours Telephone: 0776 5004 275
Out of Hours Telephone: 0776 5403 015

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 04/04/2012
PIL Salofalk 500mg gastro-resistant prolonged-release granules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 06/03/2012 and displayed until 04/04/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
Updated on 26/11/2010 and displayed until 06/03/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Change to dosage and administration
Updated on 12/10/2010 and displayed until 26/11/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 25/06/2010 and displayed until 12/10/2010
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 15/06/2010 and displayed until 25/06/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to dosage and administration
Updated on 08/09/2009 and displayed until 15/06/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to dosage and administration
Updated on 14/11/2006 and displayed until 08/09/2009
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  mesalazine